Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin in Essential Blepharospasm
NCT01259557Phase 4Completed
- Sponsor
- Medytox Inc.
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Meditoxin in benign essential blepharospasm (BEB), sponsored by Medytox Inc.. Started Aug 2010; status: completed.
02
Drugs
Meditoxin
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT01259557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259557.